{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:33:34Z","timestamp":1793406814804,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02343-3","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T12:20:11Z","timestamp":1744892411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical diagnosis and treatment of abdominal inflammatory myofibroblastic tumors"],"prefix":"10.1007","volume":"16","author":[{"given":"Qiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Ma","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"2343_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","volume":"113","author":"M Sbaraglia","year":"2021","unstructured":"Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO classification of soft tissue tumours: news and perspectives. Pathologica. 2021;113:70\u201384.","journal-title":"Pathologica"},{"key":"2343_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109937","volume":"143","author":"A Bansal","year":"2021","unstructured":"Bansal A, Goyal S, Goyal A, Jana M. WHO classification of soft tissue tumours 2020: an update and simplified approach for radiologists. Eur J Radiol. 2021;143: 109937.","journal-title":"Eur J Radiol"},{"key":"2343_CR3","doi-asserted-by":"publisher","first-page":"1042262","DOI":"10.3389\/fmed.2022.1042262","volume":"9","author":"H Al Shenawi","year":"2022","unstructured":"Al Shenawi H, Al-Shaibani SA, Al Saad SK, Al-Sindi F, Al-Sindi K, Al Shenawi N, Naguib Y, Yaghan R. An extremely rare case of malignant jejunal mesenteric inflammatory myofibroblastic tumor in a 61-year-old male patient: a case report and literature review. Front Med. 2022;9:1042262.","journal-title":"Front Med"},{"key":"2343_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fped.2018.00035","volume":"6","author":"F Camela","year":"2018","unstructured":"Camela F, Gallucci M, di Palmo E, Cazzato S, Lima M, Ricci G, Pession A. Pulmonary inflammatory myofibroblastic tumor in children: a case report and brief review of literature. Front Pediatr. 2018;6:35.","journal-title":"Front Pediatr"},{"key":"2343_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2021.100768","volume":"45","author":"P Mahajan","year":"2021","unstructured":"Mahajan P, Casanova M, Ferrari A, Fordham A, Trahair T, Venkatramani R. Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges. Curr Probl Cancer. 2021;45: 100768.","journal-title":"Curr Probl Cancer"},{"key":"2343_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.advms.2022.02.002","volume":"67","author":"K Siemion","year":"2022","unstructured":"Siemion K, Reszec-Gielazyn J, Kisluk J, Roszkowiak L, Zak J, Korzynska A. What do we know about inflammatory myofibroblastic tumors?\u2014a systematic review. Adv Med Sci. 2022;67:129\u201338.","journal-title":"Adv Med Sci"},{"key":"2343_CR7","doi-asserted-by":"publisher","first-page":"1349692","DOI":"10.3389\/fonc.2024.1349692","volume":"14","author":"Y Meng","year":"2024","unstructured":"Meng Y, Xie J, Liang Y, Wu M, Lu Y, Lu Q. Inflammatory myofibroblastic tumor in the liver: a case report. Front Oncol. 2024;14:1349692.","journal-title":"Front Oncol"},{"key":"2343_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.543078","volume":"9","author":"M Da","year":"2021","unstructured":"Da M, Qian B, Mo X, Xu C, Wu H, Jiang B, Peng W, Qi J, Sun J, Wu K. Inflammatory myofibroblastic tumors in children: a clinical retrospective study on 19 cases. Front Pediatr. 2021;9: 543078.","journal-title":"Front Pediatr"},{"key":"2343_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.radcr.2020.12.027","volume":"16","author":"A Gupta","year":"2021","unstructured":"Gupta A, Sharma S, Mittal A, Barwad A, Rastogi S. Recurrent infantile inflammatory myofibroblastic tumor of mesentery\u2013case report and review of imaging findings. Radiol Case Rep. 2021;16:504\u201310.","journal-title":"Radiol Case Rep"},{"key":"2343_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.737099","volume":"11","author":"M Liao","year":"2021","unstructured":"Liao M, Wang C, Zhang B, Jiang Q, Liu J, Liao J. Distinguishing hepatocellular carcinoma from hepatic inflammatory pseudotumor using a nomogram based on contrast-enhanced ultrasound. Front Oncol. 2021;11: 737099.","journal-title":"Front Oncol"},{"key":"2343_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4254\/wjh.v12.i4.170","volume":"12","author":"A Filips","year":"2020","unstructured":"Filips A, Maurer MH, Montani M, Beldi G, Lachenmayer A. Inflammatory myofibroblastic tumor of the liver: a case report and review of literature. World J Hepatol. 2020;12:170\u201383.","journal-title":"World J Hepatol"},{"key":"2343_CR12","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.3390\/cancers14153662","volume":"14","author":"L Gros","year":"2022","unstructured":"Gros L, Dei Tos AP, Jones RL, Digklia A. Inflammatory myofibroblastic tumour: state of the art. Cancers. 2022;14:3662.","journal-title":"Cancers"},{"key":"2343_CR13","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","volume":"122","author":"G Nocturne","year":"2013","unstructured":"Nocturne G, Boudaoud S, Miceli-Richard C, Viengchareun S, Lazure T, Nititham J, Taylor KE, Ma A, Busato F, Melki J, et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren\u2019s syndrome. Blood. 2013;122:4068\u201376.","journal-title":"Blood"},{"key":"2343_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.18.00297","volume":"3","author":"T Trahair","year":"2019","unstructured":"Trahair T, Gifford AJ, Fordham A, Mayoh C, Fadia M, Lukeis R, Wood AC, Valvi S, Walker RD, Blackburn J, et al. Crizotinib and surgery for long-term disease control in children and adolescents with ALK-positive inflammatory myofibroblastic tumors. JCO Precis Oncol. 2019;3:1.","journal-title":"JCO Precis Oncol"},{"key":"2343_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/PAP.0000000000000284","volume":"28","author":"JH Choi","year":"2021","unstructured":"Choi JH, Ro JY. The 2020 WHO classification of tumors of soft tissue: selected changes and new entities. Adv Anat Pathol. 2021;28:44\u201358.","journal-title":"Adv Anat Pathol"},{"key":"2343_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5603\/ARM.2018.0007","volume":"86","author":"A Khatri","year":"2018","unstructured":"Khatri A, Agrawal A, Sikachi RR, Mehta D, Sahni S, Meena N. Inflammatory myofibroblastic tumor of the lung. Adv Respir Med. 2018;86:27\u201335.","journal-title":"Adv Respir Med"},{"key":"2343_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5001\/omj.2018.45","volume":"33","author":"MR Bashir","year":"2018","unstructured":"Bashir MR, Al Sohaibani MO, Al-Rikabi AC. An unusual case of inflammatory myofibroblastic tumor of the appendix masquerading as acute appendicitis. Oman Med J. 2018;33:250\u20132.","journal-title":"Oman Med J"},{"key":"2343_CR18","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.3934\/mbe.2019339","volume":"16","author":"GX Fu","year":"2019","unstructured":"Fu GX, Xu CC, Yao NF, Gu JZ, Jiang HL, Han XF. Inflammatory myofibroblastic tumor: a demographic, clinical and therapeutic study of 92 cases. Math Biosci Eng. 2019;16:6794\u2013804.","journal-title":"Math Biosci Eng"},{"key":"2343_CR19","volume":"15","author":"A Taiymi","year":"2023","unstructured":"Taiymi A, Meryem N, Bouziane M, Zazour A, Kharrasse G, Khannoussi W, Ismaili Z. Abdominal inflammatory myofibroblastic tumour presenting as a pancreatic mass: a case report. Cureus. 2023;15: e41213.","journal-title":"Cureus"},{"key":"2343_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3892\/ol.2020.12312","volume":"21","author":"W Song","year":"2021","unstructured":"Song W, Zhu Y. Clinical characteristics and outcomes of 17 cases of inflammatory myofibroblastic tumor at a university hospital in China. Oncol Lett. 2021;21:51.","journal-title":"Oncol Lett"},{"key":"2343_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4143\/crt.2022.894","volume":"55","author":"X Liu","year":"2023","unstructured":"Liu X, Gong C, Zhang J, Feng W, Guo Y, Sang Y, Wang C, Chen Y, Wang J, Yu L, et al. Clinicopathological analysis and treatment of adult patients with inflammatory myofibroblastic tumor: a 15-year single- center study. Cancer Res Treat. 2023;55:1001\u201310.","journal-title":"Cancer Res Treat"},{"key":"2343_CR22","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.asjsur.2022.10.054","volume":"46","author":"E Wang","year":"2023","unstructured":"Wang E, Zhang L, Wang Y, Zhang M. Epstein-Barr virus-negative inflammatory pseudotumor-like variant of follicular dendritic cell sarcoma of the liver: a case report. Asian J Surg. 2023;46:1846\u20137.","journal-title":"Asian J Surg"},{"key":"2343_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12672-024-01039-4","volume":"15","author":"Q Shen","year":"2024","unstructured":"Shen Q, Liu X, Zhang L, Li T, Zhou J. Inflammatory myofibroblastic tumor of the liver after adrenal neuroblastoma surgery: a case report. Discov Oncol. 2024;15:174.","journal-title":"Discov Oncol"},{"key":"2343_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2019.12.021","volume":"127","author":"M Casanova","year":"2020","unstructured":"Casanova M, Brennan B, Alaggio R, Kelsey A, Orbach D, van Noesel MM, Corradini N, Minard-Colin V, Zanetti I, Bisogno G, et al. Inflammatory myofibroblastic tumor: the experience of the European pediatric soft tissue sarcoma study group (EpSSG). Eur J Cancer. 2020;127:123\u20139.","journal-title":"Eur J Cancer"},{"key":"2343_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jjco\/hyad074","volume":"53","author":"K Nakano","year":"2023","unstructured":"Nakano K. Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy. Jpn J Clin Oncol. 2023;53:885\u201392.","journal-title":"Jpn J Clin Oncol"},{"key":"2343_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.15586\/jkcvhl.v9i4.238","volume":"9","author":"A Ariafar","year":"2022","unstructured":"Ariafar A, Ahmed F, Khorshidi A, Torabi-Nezhad S, Hosseini SH. Inflammatory myofibroblastic tumor of the right kidney mimicking a locally advanced renal carcinoma: a case report. J Kidney Cancer VHL. 2022;9:14\u20138.","journal-title":"J Kidney Cancer VHL"},{"key":"2343_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.14701\/ahbps.2021.25.2.287","volume":"25","author":"EJ Jang","year":"2021","unstructured":"Jang EJ, Kim KW, Kang SH, Pak MG, Han SH. Inflammatory myofibroblastic tumors arising from pancreas head and peri-splenic area mimicking a malignancy. Ann Hepatobiliary Pancreat Surg. 2021;25:287\u201392.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"2343_CR28","volume":"15","author":"G Desai","year":"2023","unstructured":"Desai G, Parikh DM, Wagle PK. A giant solid-cystic gastric inflammatory myofibroblastic tumor: a case report and literature review. Cureus. 2023;15: e37167.","journal-title":"Cureus"},{"key":"2343_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2022.106990","volume":"93","author":"TH Li","year":"2022","unstructured":"Li TH, Yang FF, Lee CT, Chan RH. Intra-abdominal multicentric inflammatory myofibroblastic tumors mimicking ruptured appendicitis. Int J Surg Case Rep. 2022;93: 106990.","journal-title":"Int J Surg Case Rep"},{"key":"2343_CR30","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00384-020-03522-0","volume":"35","author":"S Karaisli","year":"2020","unstructured":"Karaisli S, Kamer E, Ekinci N, Cengiz F, Er A, Peskersoy M. Inflammatory myofibroblastic tumour of the colon: 2 case reports and a comprehensive review of the literature. Int J Colorectal Dis. 2020;35:947\u201358.","journal-title":"Int J Colorectal Dis"},{"key":"2343_CR31","doi-asserted-by":"publisher","DOI":"10.2174\/0115672018342513241230061704","author":"N Sharma","year":"2025","unstructured":"Sharma N, Kumar A, Sambhakar S, Bhatia D, Hussain S, Mursal M, Singh B, Narayan KP. Recent Advances in Nanotherapeutics and Theranostics for Squamous Cell Carcinoma: A Comprehensive Review. Curr Drug Deliv. 2025. https:\/\/doi.org\/10.2174\/0115672018342513241230061704.","journal-title":"Curr Drug Deliv"},{"key":"2343_CR32","doi-asserted-by":"crossref","unstructured":"Kumar A, Dhiman C, Narayan KP, Kumar M, Sharma M. Nanotherapeutics:Restoring Gut-Dybiosis and inducing cancer apoptosis.IGI Global 2025.28.","DOI":"10.4018\/979-8-3693-7728-4.ch007"},{"key":"2343_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fped.2019.00039","volume":"7","author":"J Qian","year":"2019","unstructured":"Qian J, Zhu K, Ye J. Ultrasonic manifestations of mesenteric inflammatory myofibroblastic tumors in children. Front Pediatr. 2019;7:39.","journal-title":"Front Pediatr"},{"key":"2343_CR34","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s11864-023-01144-6","volume":"24","author":"QA Wang","year":"2023","unstructured":"Wang QA, Chen HW, Wu RC, Wu CE. Update of diagnosis and targeted therapy for alk(+) inflammation myofibroblastic tumor. Curr Treat Options Oncol. 2023;24:1683\u2013702.","journal-title":"Curr Treat Options Oncol"},{"key":"2343_CR35","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.21873\/anticanres.15054","volume":"41","author":"K Yamamura","year":"2021","unstructured":"Yamamura K, Beppu T, Oda E, Sato N, Yuki H, Motohara T, Miyamoto H, Miyamura S, Onishi K, Komohara Y, Akahoshi S. Hepatic inflammatory pseudotumor mimicking malignant tumor with rare onset of intra-abdominal hemorrhage. Anticancer Res. 2021;41:2727\u201332.","journal-title":"Anticancer Res"},{"key":"2343_CR36","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1007\/s00261-022-03555-9","volume":"47","author":"L Calistri","year":"2022","unstructured":"Calistri L, Maraghelli D, Nardi C, Vidali S, Rastrelli V, Crocetti L, Grazioli L, Colagrande S. Magnetic resonance imaging of inflammatory pseudotumor of the liver: a 2021 systematic literature update and series presentation. Abdom Radiol. 2022;47:2795\u2013810.","journal-title":"Abdom Radiol"},{"key":"2343_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/deo2.243","volume":"4","author":"Y Masuda","year":"2024","unstructured":"Masuda Y, Kanazawa Y, Goto O, Kakinuma D, Higuchi K, Koizumi E, Nakata R, Sakurazawa N, Ando F, Suzuki M, et al. Primary gastric inflammatory myofibroblastic tumor treated with non-exposed endoscopic wall-inversion surgery (NEWS): a case report and literature review. DEN Open. 2024;4: e243.","journal-title":"DEN Open"},{"key":"2343_CR38","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.2169\/internalmedicine.0987-22","volume":"62","author":"H Yamada","year":"2023","unstructured":"Yamada H, Funasaka K, Nakagawa M, Hirayama Y, Horiguchi N, Nagasaka M, Nakagawa Y, Kuzuya T, Hashimoto S, Miyahara R, et al. Large inflammatory myofibroblastic tumor of the esophagus: a case report and literature review. Intern Med. 2023;62:3473\u20137.","journal-title":"Intern Med"},{"key":"2343_CR39","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1148\/rg.2018170201","volume":"38","author":"MA Manning","year":"2018","unstructured":"Manning MA, Paal EE, Srivastava A, Mortele KJ. Nonepithelial neoplasms of the pancreas, part 2: malignant tumors and tumors of uncertain malignant potential from the radiologic pathology archives. Radiographics. 2018;38:1047\u201372.","journal-title":"Radiographics"},{"key":"2343_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3941\/jrcr.v16i1.3928","volume":"16","author":"A Budylev","year":"2022","unstructured":"Budylev A, Solar I, Kessner R, Aizic A. ROS1-positive inflammatory myofibroblastic tumor of the small bowel causing obstruction: a case report. J Radiol Case Rep. 2022;16:14\u201321.","journal-title":"J Radiol Case Rep"},{"key":"2343_CR41","first-page":"77","volume":"21","author":"C Ma","year":"2018","unstructured":"Ma C, Lu J, Chen G, Wang W, Su F, Su X. Inflammatory myofibroblastic tumor mimicking lymphoma on (18)F-FDG PET\/CT. Report of a case and review of the literature. Hell J Nucl Med. 2018;21:77\u201380.","journal-title":"Hell J Nucl Med"},{"key":"2343_CR42","volume":"16","author":"NC Parker","year":"2024","unstructured":"Parker NC, Singanallur P, Faiek S, Gao J, White P. Inflammatory myofibroblastic tumor after receiving treatment for non-small cell carcinoma. Cureus. 2024;16: e59359.","journal-title":"Cureus"},{"key":"2343_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.xjon.2023.12.006","volume":"17","author":"M Vounckx","year":"2024","unstructured":"Vounckx M, Jansen YJL, Fadaei S, Geers C, De Pauw V, Smets D. Unraveling the spectrum of inflammatory myofibroblastic tumors in the lung: a comprehensive case series highlighting endobronchial, pleural, and lung parenchymal tumors. JTCVS Open. 2024;17:297\u2013305.","journal-title":"JTCVS Open"},{"key":"2343_CR44","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3892\/etm.2021.10380","volume":"22","author":"Y Wang","year":"2021","unstructured":"Wang Y, Shen L, Yun T, Zhu C, Wang P, Wang S. Clinicopathological features of gastric inflammatory myofibroblastic tumor: report of five cases. Exp Ther Med. 2021;22:948.","journal-title":"Exp Ther Med"},{"key":"2343_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.sjopt.2018.04.001","volume":"32","author":"D Strianese","year":"2018","unstructured":"Strianese D, Tranfa F, Finelli M, Iuliano A, Staibano S, Mariniello G. Inflammatory myofibroblastic tumor of the orbit: a clinico-pathological study of 25 cases. Saudi J Ophthalmol. 2018;32:33\u20139.","journal-title":"Saudi J Ophthalmol"},{"key":"2343_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/PAP.0000000000000293","volume":"28","author":"JH Choi","year":"2021","unstructured":"Choi JH, Ro JY. The 2020 WHO classification of tumors of bone: an updated review. Adv Anat Pathol. 2021;28:119\u201338.","journal-title":"Adv Anat Pathol"},{"key":"2343_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-224549","author":"E Cerier","year":"2018","unstructured":"Cerier E, Beal EW, Dillhoff ME. Inflammatory myofibroblastic tumour: an unusual presentation including small bowel obstruction and palpable abdominal mass. BMJ Case Rep. 2018. https:\/\/doi.org\/10.1136\/bcr-2018-224549.","journal-title":"BMJ Case Rep"},{"key":"2343_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13019-021-01528-5","volume":"16","author":"F Yang","year":"2021","unstructured":"Yang F, Zhang W, Han C, Jiang H. A case of pulmonary inflammatory myofibroblastic tumor treated with bronchoscopic therapy plus lobectomy. J Cardiothorac Surg. 2021;16:144.","journal-title":"J Cardiothorac Surg"},{"key":"2343_CR49","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11748-019-01231-2","volume":"68","author":"JS Yun","year":"2020","unstructured":"Yun JS, Song SY, Na KJ, Kim S, Choi YD. Inflammatory myofibroblastic tumor arising from the ascending aorta mimicking a thymoma. Gen Thorac Cardiovasc Surg. 2020;68:1193\u20135.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2343_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152535","volume":"215","author":"K Wang","year":"2019","unstructured":"Wang K, Guo R, Siegal GP, Wei S. Inflammatory myofibroblastic tumor of bone harboring an ALK gene amplification. Pathol Res Pract. 2019;215: 152535.","journal-title":"Pathol Res Pract"},{"key":"2343_CR51","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1097\/PAS.0000000000001120","volume":"42","author":"N Mohammad","year":"2018","unstructured":"Mohammad N, Haimes JD, Mishkin S, Kudlow BA, Leong MY, Chew SH, Koay E, Whitehouse A, Cope N, Ali RH, et al. ALK is a specific diagnostic marker for inflammatory myofibroblastic tumor of the uterus. Am J Surg Pathol. 2018;42:1353\u20139.","journal-title":"Am J Surg Pathol"},{"key":"2343_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.934887","volume":"12","author":"W He","year":"2022","unstructured":"He W, Ji X, Song C, Song S, Liu L. Case report: efficacy of ensartinib treatment in pulmonary inflammatory myofibroblastic tumor with a rare GCC2-ALK fusion. Front Oncol. 2022;12: 934887.","journal-title":"Front Oncol"},{"key":"2343_CR53","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1097\/PAS.0000000000001904","volume":"46","author":"H Kuisma","year":"2022","unstructured":"Kuisma H, Jokinen V, Pasanen A, Heikinheimo O, Karhu A, V\u00e4lim\u00e4ki N, Aaltonen L, B\u00fctzow R. Histopathologic and molecular characterization of uterine leiomyoma-like inflammatory myofibroblastic tumor: comparison to molecular subtypes of uterine leiomyoma. Am J Surg Pathol. 2022;46:1126\u201336.","journal-title":"Am J Surg Pathol"},{"key":"2343_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/PAS.0000000000001756","volume":"46","author":"K Collins","year":"2022","unstructured":"Collins K, Ramalingam P, Euscher ED, Reques Llanos A, Garc\u00eda A, Malpica A. Uterine inflammatory myofibroblastic neoplasms with aggressive behavior, including an epithelioid inflammatory myofibroblastic sarcoma: a clinicopathologic study of 9 cases. Am J Surg Pathol. 2022;46:105\u201317.","journal-title":"Am J Surg Pathol"},{"key":"2343_CR55","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/PAS.0000000000000801","volume":"41","author":"JD Haimes","year":"2017","unstructured":"Haimes JD, Stewart CJR, Kudlow BA, Culver BP, Meng B, Koay E, Whitehouse A, Cope N, Lee JC, Ng T, et al. Uterine inflammatory myofibroblastic tumors frequently harbor ALK fusions with IGFBP5 and THBS1. Am J Surg Pathol. 2017;41:773\u201380.","journal-title":"Am J Surg Pathol"},{"key":"2343_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/his.12910","volume":"69","author":"H Yamamoto","year":"2016","unstructured":"Yamamoto H, Yoshida A, Taguchi K, Kohashi K, Hatanaka Y, Yamashita A, Mori D, Oda Y. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Histopathology. 2016;69:72\u201383.","journal-title":"Histopathology"},{"key":"2343_CR57","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1177\/0300060518780873","volume":"46","author":"A Takahashi","year":"2018","unstructured":"Takahashi A, Kurosawa M, Uemura M, Kitazawa J, Hayashi Y. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report. J Int Med Res. 2018;46:3498\u2013503.","journal-title":"J Int Med Res"},{"key":"2343_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.humpath.2019.12.006","volume":"97","author":"EH Cheek","year":"2020","unstructured":"Cheek EH, Fadra N, Jackson RA, Davila JI, Sukov WR, Uckerman MT, Clayton A, Keeney GL, Halling KC, Torres-Mora J, Schoolmeester JK. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion. Hum Pathol. 2020;97:29\u201339.","journal-title":"Hum Pathol"},{"key":"2343_CR59","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jtho.2018.12.003","volume":"14","author":"JC Chang","year":"2019","unstructured":"Chang JC, Zhang L, Drilon AE, Chi P, Alaggio R, Borsu L, Benayed R, Travis WD, Ladanyi M, Antonescu CR. Expanding the molecular characterization of thoracic inflammatory myofibroblastic tumors beyond ALK gene rearrangements. J Thorac Oncol. 2019;14:825\u201334.","journal-title":"J Thorac Oncol"},{"key":"2343_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3389\/fonc.2020.00489","volume":"10","author":"D Racanelli","year":"2020","unstructured":"Racanelli D, Brenca M, Baldazzi D, Goeman F, Casini B, De Angelis B, Guercio M, Milano GM, Tamborini E, Busico A, et al. Next-generation sequencing approaches for the identification of pathognomonic fusion transcripts in sarcomas: the experience of the Italian ACC sarcoma working group. Front Oncol. 2020;10:489.","journal-title":"Front Oncol"},{"key":"2343_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.831952","volume":"9","author":"C Chen","year":"2022","unstructured":"Chen C, Huang M, He H, Wu S, Liu M, He J, Zang H, Xu R. Inflammatory myofibroblastic tumor of the urinary bladder: an 11-year retrospective study from a single center. Front Med. 2022;9: 831952.","journal-title":"Front Med"},{"key":"2343_CR62","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.4103\/jomfp.jomfp_338_20","volume":"26","author":"L Goyal","year":"2022","unstructured":"Goyal L, Rao S, Reddy GS, Agarwal P. Inflammatory myofibroblastic tumor of anterior maxillary gingiva: an unusual clinical presentation. J Oral Maxillofac Pathol. 2022;26:S73-s76.","journal-title":"J Oral Maxillofac Pathol"},{"key":"2343_CR63","first-page":"1604","volume":"8","author":"J Tao","year":"2015","unstructured":"Tao J, Zhou ML, Zhou SH. Inflammatory myofibroblastic tumors of the head and nec. Int J Clin Exp Med. 2015;8:1604\u201310.","journal-title":"Int J Clin Exp Med"},{"key":"2343_CR64","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2169\/internalmedicine.3599-19","volume":"59","author":"N Imazu","year":"2020","unstructured":"Imazu N, Shibata M, Koya Y, Morino K, Honma Y, Senju M, Watanabe T, Harada M. Hepatic inflammatory pseudotumor protruding from the liver surface and directly penetrating the colon. Intern Med. 2020;59:527\u201332.","journal-title":"Intern Med"},{"key":"2343_CR65","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/children9030307","volume":"9","author":"Y Dong","year":"2022","unstructured":"Dong Y, Zahid KR, Han Y, Hu P, Zhang D. Treatment of pediatric inflammatory myofibroblastic tumor: the experience from China children\u2019s medical center. Children. 2022;9:307.","journal-title":"Children"},{"key":"2343_CR66","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036558","volume":"102","author":"C Yuan","year":"2023","unstructured":"Yuan C, Fan J, Xu L. Inflammatory myofibroblastic tumor of the upper arm: a case report. Medicine (Baltimore). 2023;102: e36558.","journal-title":"Medicine (Baltimore)"},{"key":"2343_CR67","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/1759-7714.14914","volume":"14","author":"H Iwai","year":"2023","unstructured":"Iwai H, Yanagawa N, Deguchi H, Tomoyasu M, Shigeeda W, Kaneko Y, Yoshimura R, Kanno H, Sugai M, Shikanai S, et al. Surgical treatment for lung metastasis of inflammatory myofibroblastic tumor of the lung: a case report. Thorac Cancer. 2023;14:1644\u20137.","journal-title":"Thorac Cancer"},{"key":"2343_CR68","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12032-018-1161-0","volume":"35","author":"AES Sagar","year":"2018","unstructured":"Sagar AES, Jimenez CA, Shannon VR. Clinical and histopathologic correlates and management strategies for inflammatory myofibroblastic tumor of the lung. A case series and review of the literature. Med Oncol. 2018;35:102.","journal-title":"Med Oncol"},{"key":"2343_CR69","first-page":"e1777","volume":"25","author":"GG Baldi","year":"2020","unstructured":"Baldi GG, Brahmi M, Lo Vullo S, Cojocaru E, Mir O, Casanova M, Vincenzi B, De Pas TM, Grignani G, Pantaleo MA, et al. The activity of chemotherapy in inflammatory myofibroblastic tumors: a multicenter. Eur Retrospect Case Series Anal Oncol. 2020;25:e1777\u201384.","journal-title":"Eur Retrospect Case Series Anal Oncol"},{"key":"2343_CR70","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.3390\/ijms20163939","volume":"20","author":"Z Tang","year":"2019","unstructured":"Tang Z, Wang L, Tang G, Medeiros LJ. Fluorescence in situ hybridization (FISH) for detecting anaplastic lymphoma kinase (ALK) rearrangement in lung cancer: clinically relevant technical aspects. Int J Mol Sci. 2019;20:3939.","journal-title":"Int J Mol Sci"},{"key":"2343_CR71","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s43046-020-00038-0","volume":"32","author":"R Biswas","year":"2020","unstructured":"Biswas R, Halder A, Gangopadhyay M, Biswas D. Inflammatory myofibroblastic tumor of maxillary sinus successfully treated with radiotherapy and corticosteroid: report of a rare case. J Egypt Natl Canc Inst. 2020;32:26.","journal-title":"J Egypt Natl Canc Inst"},{"key":"2343_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.658327","volume":"11","author":"D Comandini","year":"2021","unstructured":"Comandini D, Catalano F, Grassi M, Pesola G, Bertulli R, Guadagno A, Spina B, Mascherini M, De Cian F, Pistoia F, Rebuzzi SE. Outstanding response in a patient with ros1-rearranged inflammatory myofibroblastic tumor of soft tissues treated with crizotinib: case report. Front Oncol. 2021;11: 658327.","journal-title":"Front Oncol"},{"key":"2343_CR73","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.32604\/or.2024.050350","volume":"32","author":"P Chmiel","year":"2024","unstructured":"Chmiel P, S\u0142Owikowska A, Banaszek \u0141, Szumera CA, Szostakowski B, Spa\u0142Ek MJ, \u015awitaj T, Rutkowski P, Czarnecka AM. Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment. Oncol Res. 2024;32:1141\u201362.","journal-title":"Oncol Res"},{"key":"2343_CR74","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.21037\/tcr-22-368","volume":"11","author":"X Xu","year":"2022","unstructured":"Xu X, Li L, Zhang Y, Meng F, Xie H, Duan R. A recurrent inflammatory myofibroblastic tumor patient with two novel ALK fusions: a case report. Transl Cancer Res. 2022;11:3379\u201384.","journal-title":"Transl Cancer Res"},{"key":"2343_CR75","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/oncolo\/oyad129","volume":"28","author":"AL Hunt","year":"2023","unstructured":"Hunt AL, Nutcharoen A, Randall J, Papazian A, Deeken J, Maxwell GL, Bateman NW, Petricoin EF, Benyounes A, Conrads TP, Cannon TL. Integration of multi-omic data in a molecular tumor board reveals EGFR-associated ALK-inhibitor resistance in a patient with inflammatory myofibroblastic cancer. Oncologist. 2023;28:730\u20136.","journal-title":"Oncologist"},{"key":"2343_CR76","doi-asserted-by":"publisher","first-page":"815","DOI":"10.6004\/jnccn.2022.0035","volume":"20","author":"M von Mehren","year":"2022","unstructured":"von Mehren M, Kane JM, Agulnik M, Bui MM, Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ, et al. Soft tissue sarcoma, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:815\u201333.","journal-title":"J Natl Compr Canc Netw"},{"key":"2343_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26920","author":"TM Theilen","year":"2018","unstructured":"Theilen TM, Soerensen J, Bochennek K, Becker M, Schwabe D, Rolle U, Klingebiel T, Lehrnbecher T. Crizotinib in ALK(+) inflammatory myofibroblastic tumors-Current experience and future perspectives. Pediatr Blood Cancer. 2018. https:\/\/doi.org\/10.1002\/pbc.26920.","journal-title":"Pediatr Blood Cancer"},{"key":"2343_CR78","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S1470-2045(21)00536-2","volume":"22","author":"M Fischer","year":"2021","unstructured":"Fischer M, Moreno L, Ziegler DS, Marshall LV, Zwaan CM, Irwin MS, Casanova M, Sabado C, Wulff B, Stegert M, et al. Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study. Lancet Oncol. 2021;22:1764\u201376.","journal-title":"Lancet Oncol"},{"key":"2343_CR79","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1093\/annonc\/mdw405","volume":"27","author":"AS Mansfield","year":"2016","unstructured":"Mansfield AS, Murphy SJ, Harris FR, Robinson SI, Marks RS, Johnson SH, Smadbeck JB, Halling GC, Yi ES, Wigle D, et al. Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib. Ann Oncol. 2016;27:2111\u20137.","journal-title":"Ann Oncol"},{"key":"2343_CR80","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/jjco\/hyx133","volume":"47","author":"M Saiki","year":"2017","unstructured":"Saiki M, Ohyanagi F, Ariyasu R, Koyama J, Sonoda T, Nishikawa S, Kitazono S, Yanagitani N, Horiike A, Ninomiya H, et al. Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene. Jpn J Clin Oncol. 2017;47:1189\u201392.","journal-title":"Jpn J Clin Oncol"},{"key":"2343_CR81","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3892\/ol.2013.1260","volume":"5","author":"C Chavez","year":"2013","unstructured":"Chavez C, Hoffman MA. Complete remission of ALK-negative plasma cell granuloma (inflammatory myofibroblastic tumor) of the lung induced by celecoxib: a case report and review of the literature. Oncol Lett. 2013;5:1672\u20136.","journal-title":"Oncol Lett"},{"key":"2343_CR82","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018414","volume":"98","author":"Q Liu","year":"2019","unstructured":"Liu Q, Wei J, Liu X, Wang J. Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by Apatinib: a case report. Med. 2019;98: e18414.","journal-title":"Med"},{"key":"2343_CR83","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025972","volume":"100","author":"SA Debonis","year":"2021","unstructured":"Debonis SA, Bongiovanni A, Pieri F, Fausti V, De Vita A, Riva N, Gurrieri L, Vanni S, Diano D, Mercatali L, Ibrahim T. ALK-negative lung inflammatory myofibroblastic tumor in a young adult: a case report and literature review of molecular alterations. Medicine. 2021;100: e25972.","journal-title":"Medicine"},{"key":"2343_CR84","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/ped4.12218","volume":"4","author":"N Zhang","year":"2020","unstructured":"Zhang N, Zeng Q, Chen C, Yu J, Yan D, Xu C, Liu D, Zhang Q, Zhang X. Clinical characteristics and prognosis of pulmonary inflammatory myofibroblastic tumor: an over 10-year retrospective analysis. Pediatr Investig. 2020;4:192\u20137.","journal-title":"Pediatr Investig"},{"key":"2343_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108388","volume":"50","author":"A Raitio","year":"2024","unstructured":"Raitio A, Losty PD. Treatment and outcomes in pediatric inflammatory myofibroblastic tumors\u2014a systematic review of published studies. Eur J Surg Oncol. 2024;50: 108388.","journal-title":"Eur J Surg Oncol"},{"key":"2343_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.826705","volume":"9","author":"Q Han","year":"2022","unstructured":"Han Q, He X, Cui L, Qiu Y, Li Y, Chen H, Zhang H. Case report: early distant metastatic inflammatory myofibroblastic tumor harboring EML4-ALK fusion gene: study of two typical cases and review of literature. Front Med. 2022;9: 826705.","journal-title":"Front Med"},{"key":"2343_CR87","doi-asserted-by":"publisher","first-page":"169.e161","DOI":"10.1016\/j.repc.2022.12.007","volume":"42","author":"C Dom\u00ednguez-Massa","year":"2023","unstructured":"Dom\u00ednguez-Massa C, Do\u00f1ate-Bertol\u00edn L, Blanco-Herrera \u00d3R, Heredia-Cambra T, P\u00e9rez-Guill\u00e9n M, Mart\u00ednez-C\u00f3zar V, Mayordomo-Aranda E, Hornero-Sos F. Inflammatory myofibroblastic tumor: a rare entity with a complex diagnosis. Rev Port Cardiol. 2023;42:169.e161-169.e164.","journal-title":"Rev Port Cardiol"},{"key":"2343_CR88","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jama.2019.11058","volume":"322","author":"KC Arbour","year":"2019","unstructured":"Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA. 2019;322:764\u201374.","journal-title":"JAMA"},{"key":"2343_CR89","volume":"10","author":"J Yorke","year":"2023","unstructured":"Yorke J, Solanki K, Theegala V, Georges T, Sinha AK, Asberry DE, El Abbassi A. A rare case of incidentally diagnosed pulmonary inflammatory myofibroblastic tumour with dramatic response to crizotinib in a postpartum woman. Eur J Case Rep Intern Med. 2023;10: 003626.","journal-title":"Eur J Case Rep Intern Med"},{"key":"2343_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28220","volume":"67","author":"EV Preobrazhenskaya","year":"2020","unstructured":"Preobrazhenskaya EV, Iyevleva AG, Suleymanova AM, Tiurin VI, Mitiushkina NV, Bizin IV, Ivanstov AO, Gorustovich OA, Shelekhova KV, Kachanov DY, et al. Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors. Pediatr Blood Cancer. 2020;67: e28220.","journal-title":"Pediatr Blood Cancer"},{"key":"2343_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.966152","volume":"9","author":"A Kumar","year":"2022","unstructured":"Kumar A, Sakhare K, Bhattacharya D, Chattopadhyay R, Parikh P, Narayan KP, Mukherjee A. Communication in non-communicable diseases (NCDs) and role of immunomodulatory nutraceuticals in their management. Front Nutr. 2022;9: 966152.","journal-title":"Front Nutr"},{"key":"2343_CR92","doi-asserted-by":"crossref","unstructured":"Sharma M, Satya Sri Kotipalli R, Siva Kumar N, Kumar A, Rawat M, Dhiman C, Kumar M. Innovations in drug delivery strategies for breast cancer. IntechOpen.2024.105772","DOI":"10.5772\/intechopen.1007334"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02343-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T13:04:07Z","timestamp":1744895047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02343-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has received approval from the Ethics Committee of the First Hospital of Jilin University (Approval number: 2024-1067) and informed consent has been duly obtained from both the patients and their families.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"554"}}